Announcement from Exploring Health LLC.：Transfer of the Administrative Authority for the Patent Report of A Novel Anti-coronavirus Drug to Deqing Baiyuankang Biotech
On February 1, 2022, Exploring Health has made the use right of a novel drug patent entitled “Anti-coronavirus drug based on ACE2 and S protein binding targets and application thereof” (Certificate Number: 4863105, Patent Number: ZL -2021-1-0165852.6) open to the whole global society. Any person or company can inform us and use this patent for free in fighting COVID-19. An official report from Deqing Baiyuankang Biotech Co., Ltd. has been received.
